It may possibly lower the need for animal tests and improve predictive toxicology, cutting down the chance of late-stage failures, thus growing successes for drug builders and maximizing Added benefits for patients. This type of human-primarily based AI tactic also encourages precision drugs (by having into account diverse genetic backgrounds or co